occurr
late
earli
case
sever
acut
respiratori
syndrom
sar
southeast
china
quickli
drew
intern
attent
diseas
sicken
peopl
spread
countri
within
six
month
sinc
identif
etiolog
agent
sarscoronaviru
sarscov
develop
character
anim
model
evalu
prophylaxi
treatment
strategi
great
interest
although
sarscov
associ
subsequ
widespread
outbreak
sinc
potenti
outbreak
remain
identif
sarslik
coronaviru
chines
horsesho
bat
rhinolophu
speci
indigen
across
southeast
asia
suggest
may
repres
natur
reservoir
virus
may
introduc
human
popul
cours
infect
anim
model
abbrevi
compar
cours
sar
human
howev
mani
aspect
diseas
reproduc
anim
model
includ
agedepend
suscept
recoveri
sarscov
respiratori
tissu
secret
infect
type
type
ii
pneumocyt
bronchial
epitheli
cell
detect
viral
genom
blood
extrapulmonari
tissu
pulmonari
patholog
includ
pneumon
edema
necrot
debri
hyalin
membran
format
clinic
symptom
report
speci
find
entir
reproduc
outbr
speci
variabl
clinic
symptom
seen
outbr
speci
may
result
addit
factor
includ
infect
copathogen
stress
exist
subspeci
test
anim
use
differ
viru
strain
variat
problemat
studi
pathogenesi
vaccin
efficaci
unless
larg
enough
number
anim
includ
treatment
group
ideal
anim
model
would
demonstr
viral
replic
respiratori
tissu
histopatholog
evid
respiratori
diseas
consist
clinic
sign
diseas
includ
mortal
small
anim
model
aspect
virusassoci
diseas
seen
would
desir
reproduc
data
gener
inbr
anim
larger
number
anim
includ
statist
analysi
biolog
outcom
gener
model
satisfi
criteria
serial
passag
sarscov
respiratori
tract
young
balbc
mice
result
lethal
viru
caus
dosedepend
weight
loss
mortal
associ
higher
viral
titer
respiratori
tract
seen
wildtyp
viru
histopatholog
find
sever
pulmonari
diseas
characterist
lethal
mouseadapt
sarscov
report
adapt
sarscov
urbani
achiev
serial
passag
lung
balbc
mice
previous
describ
influenza
influenza
b
virus
lightli
anesthet
mice
inocul
intranas
tissu
cultur
infecti
dose
per
mous
sarscov
urbani
two
three
day
postinfect
dpi
peak
viral
titer
observ
lung
harvest
infect
mice
clarifi
homogen
use
inocula
continu
serial
passag
via
intranas
inocul
mice
screen
virul
mice
group
young
mice
n
inocul
lung
homogen
collect
passag
respect
weigh
daili
observ
twice
daili
sign
morbid
mortal
death
observ
follow
inocul
howev
increas
morbid
indic
weight
loss
note
mice
day
postinfect
pi
unpublish
data
mortal
observ
mice
mice
die
display
extrem
morbid
euthan
dpi
mortal
observ
mice
infect
intermedi
passag
accompani
morbid
measur
unpublish
data
supernat
lung
homogen
contain
heterogen
viru
pool
evid
upon
sequenc
analysi
cdna
fragment
gener
revers
transcriptas
pcr
rtpcr
amplif
purifi
viral
rna
vrna
dual
peak
observ
sequenc
chromatogram
sever
nucleotid
residu
indic
mix
popul
viru
pool
obtain
clonal
popul
viru
biolog
clone
three
round
termin
dilut
vero
cell
five
clone
screen
lethal
balbc
mice
clone
caus
mortal
one
clone
design
result
mortal
within
balbc
mice
age
wk
mo
mo
suscept
infect
sever
morbid
death
occur
within
follow
intranas
inocul
order
identifi
mutat
associ
lethal
phenotyp
sequenc
compar
sarscov
urbani
sequenc
initi
sarscov
viru
ident
publish
sarscov
urbani
sequenc
six
nucleotid
substitut
identifi
genom
compar
sarscov
urbani
six
substitut
predict
caus
amino
acid
substitut
six
mutat
local
open
read
frame
orf
four
mutat
orf
one
sarscov
figur
independ
analysi
conduct
institut
genom
research
rockvil
maryland
unit
state
nation
institut
allergi
infecti
diseas
niaid
contract
confirm
six
mutat
sequenc
compar
sarscov
urbani
sequenc
confirm
six
mutat
identifi
viru
respons
lethal
mice
mutat
introduc
cdna
clone
recombin
sarscov
recov
sequenc
analysi
confirm
recombin
virus
contain
appropri
mutat
set
deriv
viru
addit
gener
recombin
viru
includ
six
mutat
two
addit
recombin
gener
contain
either
two
mutat
structur
protein
gene
four
mutat
orf
respect
three
recombin
virus
demonstr
similar
kinet
level
viral
replic
compar
sarscov
infecti
clone
icsarscov
wildtyp
recombin
sarscov
urbani
gener
cdna
biolog
deriv
viru
sarscov
urbani
vitro
singlecycl
growth
analys
vero
cell
multipl
infect
moi
virus
reach
peak
replic
pfuml
hpi
slight
delay
peak
titer
figur
northern
blot
analysi
rna
infect
vero
cell
indic
genom
vrna
viral
mrna
eight
subgenom
mrna
present
similar
ratio
recombin
virus
viru
sarscov
urbani
figur
level
express
mobil
structur
protein
n
accessori
protein
orf
also
call
recombin
virus
viru
compar
sarscov
urbani
determin
western
blot
analysi
figur
although
n
somewhat
reduc
lane
figur
cultur
associ
reduc
amount
total
protein
ad
well
rather
specif
reduct
express
thu
recombin
virus
icsarscov
viru
demonstr
defect
replic
rna
protein
express
compar
sarscov
urbani
vero
cell
group
mice
inocul
serial
dilut
viru
dosedepend
weight
loss
lethal
observ
follow
infect
summar
tabl
mice
receiv
dose
viru
die
lost
initi
bodi
weight
day
pi
mice
experienc
weight
loss
excess
initi
bodi
weight
euthan
accord
anim
studi
protocol
lethal
dose
intermedi
nonleth
dose
mice
lost
initi
bodi
weight
day
pi
lower
dose
weight
loss
signific
day
pi
similarli
group
mice
inocul
serial
dilut
follow
daili
sign
morbid
indic
weight
loss
mortal
mortal
observ
mice
dose
equal
excess
tabl
similar
observ
viru
consist
observ
follow
infect
viru
mice
inocul
low
concentr
littl
signific
weight
loss
intermedi
dose
result
signific
weight
loss
mortal
thu
recapitul
phenotyp
viru
mice
inocul
highest
dose
result
mortal
tabl
mice
demonstr
signific
morbid
indic
weight
loss
rapid
lethal
observ
follow
administr
viru
recombin
clone
balbc
mice
could
result
chang
tissu
tropism
without
viremia
increas
viral
load
subsequ
necrosi
pulmonari
extrapulmonari
tissu
failur
innat
earli
adapt
immun
respons
immunopatholog
pulmonari
extrapulmonari
tissu
combin
factor
order
evalu
whether
chang
tissu
tropism
level
viral
replic
could
contribut
lethal
phenotyp
viru
viral
titer
lung
spleen
liver
brain
balbc
mice
determin
variou
time
point
follow
intranas
inocul
sarscov
urbani
mice
inocul
intranas
sarscov
urbani
dose
result
peak
viral
titer
lung
mice
dpi
lethal
subleth
dose
viru
variou
time
point
pi
mice
sacrif
tissu
harvest
subsequ
process
data
replic
experi
combin
high
titer
viru
detect
lung
mice
day
pi
figur
one
day
inocul
amount
sarscov
urbani
lung
tissu
follow
administr
lethal
dose
viru
found
replic
significantli
higher
titer
tissu
within
h
p
figur
studi
previou
studi
k
subbarao
robert
l
vogel
e
lamirand
et
al
unpublish
data
peak
viru
titer
tissu
occur
day
follow
inocul
sarscov
urbani
comparison
day
pi
viral
titer
mice
reach
persist
titer
tissu
regardless
inocul
dose
figur
furthermor
mice
inocul
subleth
dose
viru
detect
lung
day
pi
comparison
sarscov
urbani
mice
viru
detect
titer
lung
day
pi
dpi
viru
longer
consist
detect
mice
inocul
sarscov
urbani
subleth
dose
viru
figur
follow
inocul
lethal
dose
viru
viru
also
recov
spleen
brain
liver
day
day
pi
titer
rang
brain
spleen
tabl
viru
detect
frequent
liver
higher
titer
brain
spleen
viru
recov
organ
follow
inocul
sarscov
urbani
except
one
mous
sacrif
dpi
viru
detect
spleen
titer
limit
detect
tabl
although
level
viral
replic
detect
tissu
mice
modest
number
mice
viru
detect
remark
frequenc
titer
significantli
higher
observ
sarscov
urbani
mice
separ
experi
infecti
viru
also
detect
sera
mice
infect
viru
recombin
sarscov
day
pi
data
experi
suggest
presenc
viru
serum
may
facilit
mutat
gene
sinc
viru
detect
frequent
higher
titer
sera
mice
infect
sera
mice
infect
icsarscov
figur
addit
recoveri
infecti
viru
tissu
total
rna
also
isol
whole
blood
brain
kidney
liver
intestin
spleen
thymu
heart
lung
balbc
mice
infect
although
quantit
virolog
hold
biolog
relev
sinc
indic
viral
burden
measur
infecti
viru
rtpcr
vrna
subgenom
mrna
may
sensit
assay
presenc
viru
due
replic
strategi
sarscov
primer
specif
amplifi
subgenom
mrna
allow
detect
product
viral
transcript
furthermor
amplif
virusspecif
mrna
allow
distinct
vrna
may
repres
nonviabl
viru
rtpcr
amplif
genom
antigenom
subgenom
mrnaspecif
sequenc
employ
confirm
presenc
sarscov
nucleic
acid
viral
transcript
product
differ
tissu
group
four
mice
inocul
lethal
dose
viru
sarscov
urbani
mice
inocul
viru
surviv
past
day
pi
sarscov
urbani
mice
follow
day
pi
vrna
viral
mrna
amplifi
lung
mice
day
pi
contrast
vrna
amplifi
sarscov
urbani
mice
day
pi
mrna
indic
viral
transcript
consist
amplifi
day
pi
mrna
detect
late
day
pi
rtpcr
one
four
sarscov
urbani
mice
tabl
also
abl
amplifi
vrna
mrna
blood
brain
thymu
heart
spleen
mice
tabl
viral
mrna
consist
detect
rtpcr
tissu
mice
day
pi
day
pi
thymu
heart
mice
earli
day
pi
contrast
vrna
viral
mrna
detect
transient
sarscov
urbani
mice
blood
spleen
thymu
vrna
viral
mrna
detect
rtpcr
analysi
liver
intestin
kidney
sarscov
urbani
mice
tissu
may
contain
factor
inhibit
rtpcr
amplif
sarscov
rna
sinc
viru
isol
liver
homogen
mice
detect
rtpcr
viral
mrna
detect
intestin
situ
hybrid
unpublish
data
summari
viru
viralspecif
rna
detect
blood
lung
thymu
brain
spleen
liver
heart
almost
mice
contrast
viru
viralspecif
rna
detect
lung
sporad
blood
spleen
thymu
sarscov
urbani
mice
tabl
lung
mice
infect
sarscov
urbani
show
rapid
progress
focal
mild
perivascular
peribronchiolar
mononuclear
inflammatori
cell
infiltr
diffus
transient
interstiti
pneumon
day
pi
figur
occasion
ciliat
columnar
epitheli
cell
bronchiol
alveolar
pneumocyt
stain
viral
antigen
immunohistochemistri
ihc
figur
viral
antigen
detect
day
pi
mice
time
point
show
signific
pulmonari
histopatholog
unpublish
data
comparison
pulmonari
patholog
mice
infect
viru
show
rapid
progress
inflammatori
chang
figur
extens
damag
bronchiolar
alveolar
epitheli
cell
figur
chang
especi
evid
pneumocyt
mani
detach
pyknot
necrot
cell
identifi
alveolar
space
figur
inflammatori
infiltr
although
consist
identifi
gener
similar
intens
observ
lung
sarscov
urbani
mice
figur
howev
distribut
amount
viral
antigen
identifi
ihc
far
greater
lung
mice
lung
mice
infect
sarscov
urbani
figur
intracellular
sarscov
antigen
extens
abundantli
distribut
bronchiolar
epithelium
alveolar
pneumocyt
necrot
debri
within
alveoli
bronchiol
lumen
mice
figur
signific
histopatholog
chang
identifi
extrapulmonari
organ
includ
liver
spleen
thymu
brain
mice
infect
sarscov
urbani
viru
furthermor
sarscov
antigen
detect
tissu
ihc
stain
infect
young
balbc
mice
viru
result
elev
level
liver
enzym
alkalin
phosphatas
alp
sera
collect
day
pi
alp
level
significantli
higher
sera
mice
preinfect
sera
mice
serum
alp
level
mice
also
significantli
higher
mice
inocul
sarscov
p
tabl
level
liver
enzym
includ
aspart
aminotransferas
alanin
aminotransferas
gamma
glutamyl
transferas
creatin
kinas
urea
nitrogen
total
bilirubin
albumin
significantli
alter
follow
inocul
viru
unpublish
data
although
moder
elev
level
creatinin
observ
mice
signific
differ
seen
mice
suggest
associ
lethal
phenotyp
viru
furthermor
signific
lymphopenia
neutrophilia
observ
follow
infect
sarscov
viru
although
sampl
lost
due
coagul
blood
alter
lymphocyt
neutrophil
count
sever
follow
infect
viru
follow
sarscov
infect
tabl
order
determin
whether
viru
use
stringent
challeng
evalu
vaccin
antivir
therapi
design
sarscov
could
nonleth
sarscov
urbani
inocul
eight
mice
sarscov
urbani
mockimmun
addit
eight
mice
four
week
inocul
mice
bled
determin
serum
neutral
antibodi
challeng
viru
mice
follow
daili
sign
morbid
mortal
serum
neutral
antibodi
detect
low
titer
mice
mockimmun
mice
nevertheless
mice
protect
lethal
challeng
demonstr
reduc
morbid
weight
loss
compar
weight
loss
mockimmun
mice
follow
high
titer
challeng
viru
mockimmun
mice
surviv
past
day
follow
challeng
viru
figur
serial
passag
sarscov
urbani
lung
balbc
mice
result
mouseadapt
sarscov
viru
lethal
young
balbc
mice
virul
lethal
viru
result
six
mutat
sarscov
genom
occur
within
passag
balbc
mice
introduct
six
mutat
recombin
sarscov
infecti
clone
confer
lethal
phenotyp
viru
young
balbc
mice
five
six
mutat
includ
mutat
occur
nonstructur
protein
nsp
orf
occur
within
nsp
two
mutat
nsp
gene
report
one
sequenc
evolut
occur
adapt
sarscov
human
mutat
nsp
nsp
within
main
proteas
nsp
within
helicas
protein
occur
within
known
function
domain
alter
known
cleavag
site
util
process
orf
polyprotein
furthermor
mutat
viru
occur
specif
amino
acid
posit
identifi
chines
sar
molecular
epidemiolog
consortium
mutat
occur
within
known
function
domain
receptorbind
motif
rbm
report
indic
mutat
within
rbm
may
account
increas
affin
viru
cellular
receptor
angiotensin
convert
enzym
howev
mutat
viru
occur
previous
identifi
site
rbm
angiotensin
convert
enzym
interact
preliminari
find
suggest
mutat
increas
bind
sarscov
rbd
murin
enzym
report
adapt
influenza
viru
increas
virul
mice
indic
multipl
gene
product
may
interact
contribut
independ
virul
one
adapt
influenza
fmma
find
indic
four
viral
gene
segment
contribut
increas
virul
addit
analys
indic
mutat
occur
least
two
like
three
gene
product
act
synergist
account
increas
virul
recombin
icsarscov
produc
mild
pneumonia
identifi
xray
chang
macaqu
similar
clinic
diseas
note
wildtyp
sarscov
urbani
consist
find
recombin
sarscov
bear
six
novel
mouseadapt
mutat
recapitul
fatal
respiratori
diseas
phenotyp
mice
demonstr
abil
sar
molecular
clone
captur
complex
diseas
phenotyp
gener
two
recombin
sarscov
encod
two
mutat
gene
encod
four
mutat
orf
neither
lethal
tabl
balbc
mice
indic
sarscov
adapt
balbc
mice
involv
mutat
least
two
possibl
three
gene
orf
orf
orf
although
recombin
virus
bear
two
four
mutat
lethal
differ
phenotyp
sarscov
urbani
possibl
mutat
contribut
increas
viremia
figur
mutat
orf
contribut
increas
pathogen
indic
weight
loss
tabl
quantit
virolog
ihc
analysi
lung
mice
indic
extraordinarili
high
level
viral
replic
pulmonari
tissu
earli
hpi
level
replic
remain
high
day
pi
unlik
mice
viral
antigen
detect
ihc
stain
modest
level
bronchial
epithelium
alveolar
pneumocyt
day
pi
bronchial
epithelium
mice
replet
viral
antigen
day
pi
alveolar
pneumocyt
day
pi
day
pi
viral
antigen
rare
detect
lung
mice
contrast
viral
antigen
remain
abund
pneumocyt
necrot
debri
pyknot
cell
mice
day
pi
model
day
day
pi
seem
critic
time
outcom
sarscov
infect
sarscov
urbani
mice
demonstr
pronounc
transient
interstiti
inflamm
day
pi
absent
mice
transient
inflamm
associ
signific
weight
loss
coincid
begin
viral
clearanc
lung
contrast
day
pi
mice
lose
weight
necrot
cellular
debri
begin
fill
bronchiol
alveoli
day
pi
mice
lost
excess
initi
bodi
weight
sever
die
without
overt
clinic
sign
ataxia
paralysi
hunch
postur
etc
viral
titer
lung
mice
higher
mice
hpi
remain
higher
peak
level
mice
day
pi
situ
hybrid
confirm
intens
persist
signal
vrna
lung
tissu
day
pi
vrna
sarscov
urbani
nonleth
virus
less
abund
figur
object
data
relat
respiratori
distress
plethysmographi
measur
blood
gase
could
collect
practic
logist
constraint
experi
carri
anim
biosafeti
level
laboratori
howev
find
indic
mice
die
result
overwhelm
pulmonari
viral
infect
destruct
bronchiolar
epitheli
cell
alveolar
pneumocyt
viral
load
sar
case
import
determin
sever
diseas
death
mechan
diseas
lead
fatal
outcom
human
case
sar
may
differ
observ
balbc
mice
mechan
death
follow
sarscov
infect
human
particularli
rel
contribut
virusinduc
damag
immunopatholog
fulli
understood
histopatholog
document
mice
infect
viru
includ
rapid
progress
extens
damag
bronchiolar
alveolar
epitheli
cell
figur
show
featur
alveolar
edema
hyalin
membran
report
mani
patient
age
mice
infect
urbani
strain
sarscov
explain
rel
virul
strain
time
pi
lung
evalu
mice
infect
viru
develop
sever
morbid
die
within
follow
infect
surviv
long
enough
show
progress
diffus
alveolar
damag
seen
age
mice
human
patient
surviv
rel
prolong
length
time
succumb
complic
acut
infect
age
mice
follow
sarscov
infect
histopatholog
chang
indic
progress
diffus
alveolar
damag
includ
proteinac
deposit
around
alveolar
wall
intraalveolar
edema
seen
begin
day
rapid
progress
infect
extens
persist
pulmonari
replic
viru
accompani
viremia
detect
viru
extrapulmonari
site
suggest
factor
may
contribut
increas
pathogen
viru
prolong
virem
state
secondari
viremia
seen
mice
infect
observ
follow
infect
recombin
sarscov
urbani
viru
model
captur
viremia
multiorgan
involv
note
human
sar
patient
howev
sar
case
primari
site
infect
lung
perfus
tissu
harvest
mice
experi
perform
therefor
certain
detect
vrna
variou
extrapulmonari
site
mice
due
viru
carri
remain
organ
blood
howev
day
pi
mrna
variou
tissu
detect
higher
frequenc
signal
intens
whole
blood
presenc
vrna
extrapulmonari
tissu
detect
situ
hybrid
furthermor
infecti
viru
detect
day
pi
homogen
extrapulmonari
tissu
rtpcr
rna
blood
amplifi
viral
specif
product
tabl
taken
togeth
observ
support
hypothesi
viru
present
replic
low
level
extrapulmonari
tissu
balbc
mice
infect
viru
sarscov
signific
lymphopenia
neutrophilia
observ
compar
preinfect
level
mice
significantli
greater
lymphopenia
neutrophilia
mice
reflect
hematolog
evid
increas
diseas
sever
follow
viru
infect
mice
also
significantli
higher
level
alp
uninfect
mice
elev
level
alp
enzym
found
tissu
especi
concentr
liver
may
indic
cell
destruct
liver
intestin
tissu
report
elev
alp
level
sar
patient
rare
neutrophilia
lymphopenia
report
frequent
human
case
sar
although
steroid
treatment
secondari
bacteri
infect
may
specul
caus
neutrophilia
patient
sar
neutrophilia
prior
initi
steroid
treatment
absenc
bacteri
infect
addit
elev
absolut
neutrophil
count
present
independ
indic
sever
outcom
sar
human
case
definit
caus
lymphopenia
neutrophilia
elev
alp
level
identifi
human
case
sar
mous
model
mouseadapt
sarscov
viru
valuabl
tool
evalu
sarscov
vaccin
antivir
therapi
quantit
virolog
outcom
measur
avail
young
balbc
mice
challeng
sarscov
urbani
viru
replic
rapidli
high
titer
lethal
young
balbc
mice
viru
provid
stringent
challeng
sarscov
urbani
viru
evalu
efficaci
therapeut
intervent
prevent
strategi
prophylaxi
abl
rescu
mice
lethal
outcom
must
lower
viral
burden
lung
rapidli
eg
within
first
h
prophylaxi
accomplish
reduct
burden
viru
may
also
reduc
sever
immunopatholog
follow
reduct
immunopatholog
demonstr
sarscov
hamster
model
monoclon
antibodi
specif
sarscov
spike
protein
administ
day
infect
abl
arrest
rise
viral
titer
lung
similar
protect
demonstr
challeng
viru
balbc
mice
efficaci
intervent
well
proven
infect
young
balbc
mice
viru
provid
model
small
access
evalu
extens
immunolog
level
final
importantli
viru
infect
young
balbc
mice
provid
mani
element
replic
observ
acut
chronic
case
sar
infect
human
includ
sequenc
chang
adapt
sever
gene
nsp
nsp
viral
replic
histopatholog
chang
lung
infect
anim
viremia
detect
vrna
extrapulmonari
site
includ
intestin
clinic
indic
ill
includ
mortal
chang
blood
count
includ
lymphopenia
neutrophilia
avail
molecular
clone
viru
abil
gener
addit
sarscov
recombin
virus
recapitul
vivo
phenotyp
allow
detail
probe
mechan
mediat
sarscov
pathogenesi
acut
lung
damag
dose
sarscov
urbani
administ
intranas
lightli
anesthet
femal
balbc
mous
total
volum
two
day
inocul
mous
euthan
lung
remov
homogen
exgen
omni
glh
homogen
omni
intern
http
wwwomniinccom
wv
suspens
leibovitz
medium
invitrogen
http
wwwinvitrogencom
supplement
follow
antibiot
mgl
piperacillin
sigma
http
wwwsigmaaldrichcom
mgl
gentamicin
invitrogen
mgl
amphotericin
b
qualiti
biolog
http
wwwqualitybiologicalcom
lung
homogen
clarifi
lowspe
centrifug
rpm
min
supernat
administ
intranas
three
mice
process
intranas
inocul
three
femal
balbc
mice
pool
clarifi
supernat
lung
homogen
collect
dpi
repeat
time
supernat
lung
homogen
subject
three
round
termin
dilut
vero
cell
serial
dilut
ad
cell
plate
one
dilutionpl
two
three
day
later
cytopath
effect
evid
nine
well
per
plate
supernat
infect
well
collect
dilut
transfer
fresh
monolay
vero
cell
third
round
termin
dilut
five
independ
clone
screen
lethal
four
femal
balbc
mice
mortal
associ
five
clone
one
five
clone
caus
lethal
within
expand
two
passag
vero
cell
use
studi
young
femal
balbc
mice
lightli
anesthet
inocul
intranas
serial
dilut
viru
sarscov
urbani
dose
administ
unless
note
otherwis
lethal
dose
viru
dose
administ
equal
subleth
dose
dose
administ
equal
variou
time
point
pi
mice
euthan
tissu
collect
analys
determin
viral
titer
tissu
homogen
final
wv
suspens
leibovitz
medium
supplement
antibiot
tissu
homogen
clarifi
lowspe
centrifug
viru
titer
determin
vero
cell
plate
previous
describ
viru
titer
express
tissu
lower
limit
detect
tissu
homogen
clarifi
lowspe
centrifug
supernat
transfer
eppendorf
tube
http
wwweppendorfcom
clarifi
centrifug
min
vrna
extract
supernat
use
qiaamp
viral
rna
mini
kit
qiagen
http
elut
water
quantifi
measur
optic
densiti
nm
nanodrop
spectrophotomet
nanodrop
technolog
http
wwwnanodropcom
store
firststrand
cdna
gener
revers
transcript
rna
purifi
clarifi
cell
supernat
vero
cell
infect
either
sarscov
sarscov
urbani
clarifi
supernat
lung
homogen
use
reagent
brilliant
qrtpcr
plu
core
reagent
kit
stratagen
http
wwwstratagenecom
brief
vrna
heat
denatur
min
quench
ice
addit
core
rt
buffer
random
primer
dntp
mixtur
stratascript
revers
transcriptas
reaction
mixtur
revers
transcript
perform
initi
incub
min
follow
incub
denatur
firststrand
cdna
amplifi
overlap
pcr
product
span
entir
genom
three
microlit
cdna
reaction
amplifi
pcr
use
advantagehf
pcr
kit
bd
bioscienc
http
wwwbdbiosciencescom
herculas
enhanc
dna
polymeras
stratagen
per
manufactur
protocol
fifteen
pair
primer
use
gener
overlap
pcr
product
tabl
amplif
product
visual
agaros
gel
purifi
use
qiaquick
gel
extract
kit
qiagen
pcr
product
sequenc
forward
revers
direct
use
forward
revers
primer
tabl
autom
sequenc
perform
util
bigdy
termin
version
cycl
sequenc
kit
appli
biosystem
per
manufactur
instruct
abi
prism
dna
analyz
appli
biosystem
sequenc
assembl
analyz
vector
nti
auto
assembl
dna
sequenc
assembl
softwar
abi
prism
appli
biosystem
mutat
identifi
comparison
sarscov
urbani
publish
sequenc
independ
rtpcr
reaction
run
subsequ
rtpcr
product
sequenc
region
contain
put
mutat
confirm
mutat
total
rna
isol
variou
tissu
whole
blood
purifi
use
rneasi
mini
kit
qiagen
oncolumn
dnase
digest
rnasefre
dnase
set
qiagen
per
manufactur
protocol
approxim
g
tissu
cut
piec
larger
cm
one
side
collect
ml
rnalat
ambion
http
wwwambioncom
store
room
temperatur
h
subsequ
process
unus
tissu
remain
one
month
move
approxim
onehalf
g
tissu
homogen
dispos
probe
omni
intern
rlt
buffer
rneasi
mini
kit
qiagen
supplement
vv
sigma
rlt
suspens
transfer
eppendorf
microcentrifug
tube
centrifug
min
rna
purifi
per
manufactur
protocol
rna
blood
ml
per
sampl
purifi
use
qiaamp
rna
blood
mini
kit
qiagen
per
manufactur
protocol
addit
dnase
oncolumn
digest
rna
quantifi
ng
revers
transcrib
amplifi
describ
brief
total
rna
heat
denatur
min
quench
ice
addit
first
strand
buffer
rnase
block
random
primer
dntp
mixtur
stratascript
revers
transcriptas
water
reaction
revers
transcript
perform
initi
incub
min
follow
incub
denatur
three
microlit
rt
reaction
subsequ
use
pcr
primer
amplif
sequenc
nucleocapsid
gene
sarscov
forward
sarscov
revers
microglobulin
primer
use
separ
reaction
rna
quantiti
pcr
control
forward
revers
pcr
reaction
perform
total
cycl
x
advantag
cdna
polymeras
clontech
http
wwwclontechcom
dntp
mixtur
stratagen
cdna
pcr
reaction
buffer
clontech
optiprim
buffer
stratagen
supplement
qualiti
biolog
rna
amplif
sarscov
respect
tabl
six
codon
chang
c
g
c
k
identifi
compar
publish
sarscov
urbani
sequenc
insert
cdna
clone
use
construct
rescu
infecti
recombin
clone
sarscov
urbani
describ
previous
brief
mutat
two
overlap
amplicon
gener
pcr
join
primerintroduc
bsmbi
site
ligat
cdna
icsarscov
use
two
uniqu
restrict
site
flank
mutat
interest
pcr
reaction
perform
expand
long
taq
roch
appli
scienc
http
wwwrocheappliedsciencecom
cycl
extens
min
use
follow
primer
plasmid
encod
portion
icsarscov
genom
mutat
nucleotid
posit
primer
pair
cattt
gcaca
gcag
gtctc
atggc
acac
taatt
atacc
attaa
ag
acaag
aatgc
gtgc
use
second
pcr
amplif
use
primer
produc
pcr
product
digest
appropri
restrict
enzym
bglii
ligat
icsarscov
cdna
plasmid
similarli
mutat
construct
use
primer
pair
aaagc
agcac
acata
tc
c
cgctg
ctgca
gaatg
follow
amplif
primer
pcr
product
digest
appropri
restrict
enzym
bglii
ligat
icsarscov
cdna
plasmid
mutat
similarli
construct
use
primer
pair
tctcg
ttcca
gttct
gcgta
aattg
tacct
gtacc
sar
tctct
ggaac
cacct
tgtag
gtttg
tagac
gacat
cagtac
two
result
amplicon
join
follow
digest
bsmbi
purif
qiaquick
pcr
purif
kit
qiagen
product
dna
digest
bamhi
acli
insert
icsarscov
cdna
mutat
construct
use
primer
primer
ctttatatcaacgctgaggtg
primer
use
amplifi
appropri
fragment
purifi
digest
pflmi
bbvci
ligat
icsarscov
cdna
mutat
construct
use
primer
pair
aactg
ctgta
atgtc
tc
sma
mu
tctct
atgat
tacca
gttga
agtag
catc
sma
smu
tctca
tcataa
ttata
aatat
aggta
tctta
gacat
gg
sar
e
acaaa
tgcca
gctcc
two
result
amplicon
join
follow
digest
bsmbi
purif
ligat
fulllength
product
digest
insert
icsarscov
cdna
util
restrict
endonucleas
site
agei
sali
mutat
construct
use
primer
set
sma
mum
sma
mum
sar
result
amplicon
ligat
follow
digest
bsmbi
mutationcontain
product
digest
insert
icsarscov
cdna
swai
ndei
restrict
site
case
final
plasmid
mutat
plaquepurifi
virus
verifi
rtpcr
sequenc
fulllength
cdna
wildtyp
sarscov
icsarscov
mouseadapt
sarscov
recombin
produc
previous
describ
rna
transcript
fulllength
cdna
ad
vero
cell
suspens
electropor
cuvett
four
electr
puls
v
given
gene
pulser
ii
electropor
biorad
http
wwwbioradcom
similar
protocol
previous
describ
presenc
fulllength
cdna
transcript
verifi
separ
agaros
gel
visual
uv
light
transfect
vero
cell
seed
flask
incub
virus
plaqu
purifi
vero
cell
sarscov
urbani
icsarscov
urbani
infecti
clone
icsarscov
six
mutat
found
icsarscov
four
mutat
found
replicas
gene
orf
icsarscov
two
mutat
found
structur
gene
virus
propag
vero
cell
eagl
mem
supplement
fetal
calf
serum
kanamycin
gentamicin
humidifi
incub
cultur
vero
cell
infect
duplic
moi
h
cell
monolay
wash
twice
ml
pb
overlaid
complet
mem
supernat
collect
variou
time
pi
viru
quantifi
plaqu
assay
vero
cell
dish
plaqu
visual
neutral
red
stain
count
h
cultur
vero
cell
inocul
sarscov
virus
moi
incub
h
hpi
intracellular
rna
isol
use
trizol
reagent
invitrogen
direct
manufactur
total
mrna
treat
glyoxal
separ
agaros
gel
use
northernmaxgli
accord
manufactur
direct
ambion
rna
transfer
brightstarplu
membran
ambion
h
crosslink
membran
uv
light
blot
prehybrid
probe
n
oligodeoxynucleotid
probe
gccgcct
ctgct
b
b
ccct
b
ct
b
gc
biotinyl
nucleotid
design
subscript
b
blot
hybrid
overnight
wash
low
high
stringenc
buffer
recommend
manufactur
filter
incub
strepavidinap
wash
incub
chemiluminesc
substrat
cdpstar
ambion
blot
overlaid
film
develop
ten
hour
pi
sarscov
urbani
biolog
deriv
clone
icsarscov
cell
wash
pb
lyse
buffer
contain
mm
trishcl
ph
mm
nacl
deoxycholin
sodium
dodecyl
sulphat
sd
supernat
clarifi
nuclei
ad
equal
volum
mm
sd
result
final
sd
concentr
sampl
heat
inactiv
min
prior
transfer
biosafeti
level
transfer
biosafeti
level
sampl
heat
inactiv
min
use
equival
sampl
volum
load
onto
readi
gel
biorad
transfer
pvdf
membran
biorad
detect
sarscov
antigen
blot
probe
polyclon
mous
antisera
direct
venezuelan
equin
enceph
viru
replicon
particl
vrp
express
sarscov
orf
vrp
n
vrpn
protein
dilut
sarscov
orf
n
antisera
dilut
done
blotto
tween
develop
use
ecl
chemiluminesc
reagent
amersham
http
wwwamershambiosciencescom
paraffinembed
section
thick
probe
utplabel
riboprob
complementari
n
gene
sarscov
urbani
sindbi
viru
genom
neg
control
use
previous
describ
method
brief
follow
treatment
prevent
nonspecif
probe
bind
tissu
incub
overnight
either
probe
hybrid
buffer
slide
wash
dehydr
coat
nbt
emuls
eastman
kodak
http
wwwkodakcom
incub
prior
develop
posit
signal
determin
silver
grain
deposit
evalu
light
microscopi
logtransform
viru
titer
compar
mannwhitney
u
test
statist
signific
assign
differ
pvalu
lung
liver
spleen
thymu
brain
obtain
individu
mice
euthan
variou
time
point
fix
neutral
buffer
formalin
process
histopatholog
ihc
examin
describ
tissu
section
stain
hematoxylin
eosin
use
immunoalkalin
phosphatas
techniqu
hyperimmun
rabbit
antisarscov
nucleocapsid
protein
antibodi
dilut
